Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-03-26 @ 3:14 PM
NCT ID:
NCT07490561
Eligibility Criteria:
Inclusion Criteria:
* 1: Female age ≥ 35 years
* 2: First or second vitrified-warmed embryo transfer cycle
* 3: Quality of embryos for transfer meeting the criteria: Grade I, II, CP or above (cleavage-stage embryos); Grade 4BC/CB or above (blastocysts)
* 4: Provide written informed consent
Exclusion Criteria:
* 1: Use of donor oocytes or sperm, or planned preimplantation genetic testing (PGT)
* 2: Severe immune or chromosomal abnormalities
* 3: Uterine cavity abnormalities (i.e., adenomyosis, submucous uterine fibroids, hydrosalpinx, uterine septum, and endometrial polyps)
* 4: Embryos with an abnormal zona pellucida
* 5: Complicated with severe underlying diseases (e.g., uncontrolled hypertension/diabetes mellitus, active malignant tumors)
* 6: A history of recurrent implantation failure (≥2 cycles) or recurrent miscarriage (≥2 episodes)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
35 Years
Maximum Age:
50 Years
Study:
NCT07490561
Study Brief:
Protocol Section:
NCT07490561